In vitro transforming potential, intracellular signaling properties and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu and Arg886Trp

in Endocrine-Related Cancer
Authors:
Hugo Prazeres Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Porto, Portugal
Molecular Pathology Service, Portuguese Institute of Oncology of Coimbra FG, Coimbra, Portugal
Department of Pathology, Medical Faculty, University of Porto, Porto, Portugal

Search for other papers by Hugo Prazeres in
Current site
Google Scholar
PubMed
Close
,
Joana P Couto Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Porto, Portugal

Search for other papers by Joana P Couto in
Current site
Google Scholar
PubMed
Close
,
Fernando Rodrigues Endocrinology Service, Portuguese Institute of Oncology of Coimbra FG, Coimbra, Portugal

Search for other papers by Fernando Rodrigues in
Current site
Google Scholar
PubMed
Close
,
João Vinagre Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Porto, Portugal

Search for other papers by João Vinagre in
Current site
Google Scholar
PubMed
Close
,
Joana Torres Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Porto, Portugal

Search for other papers by Joana Torres in
Current site
Google Scholar
PubMed
Close
,
Vitor Trovisco Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Porto, Portugal

Search for other papers by Vitor Trovisco in
Current site
Google Scholar
PubMed
Close
,
Teresa C Martins Molecular Pathology Service, Portuguese Institute of Oncology of Coimbra FG, Coimbra, Portugal

Search for other papers by Teresa C Martins in
Current site
Google Scholar
PubMed
Close
,
Manuel Sobrinho-Simões Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Porto, Portugal
Department of Pathology, Medical Faculty, University of Porto, Porto, Portugal

Search for other papers by Manuel Sobrinho-Simões in
Current site
Google Scholar
PubMed
Close
, and
Paula Soares Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Porto, Portugal
Department of Pathology, Medical Faculty, University of Porto, Porto, Portugal

Search for other papers by Paula Soares in
Current site
Google Scholar
PubMed
Close

Free access

Sign up for journal news

The authors and journal apologise for an omission in the above paper, which appeared in volume 18 part 4, pages 401–412. The text ‘This work was also supported by FEDER funds through Programa Operacional Factores de Competitividade – COMPETE (FCOMP-01-0124-FEDER 011267).’ was omitted from the Funding section given on page 409.

The correct Funding section is given in full below:

Funding

The authors would like to acknowledge funding from grants from the Portuguese Foundation for Science and Technology (SFRH/BD/30041/2006 and PTDC/SAU-OBD/101242/2008), the Portuguese Society of Endocrinology and Metabolism (Edward Limber Prize) and the Portuguese Ministry of Health (13/2007). IPATIMUP is an associated Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology. This work was also supported by FEDER funds through Programa Operacional Factores de Competitividade – COMPETE (FCOMP-01-0124-FEDER 011267).